In the News | Friends of Cancer Research

You are here

In the News

February 21, 2020
This is a formidable challenge. Cancer trials were, and remain, notoriously time-consuming to launch, expensive to run, and difficult to enroll patients to. A deeper understanding of cancer biology... Read more
February 5, 2020
FDA's cancer center is working with patient and research groups on guidance to broaden the number of patients eligible to join clinical trials, officials said Wednesday.   The Oncology Center for... Read more
January 31, 2020
SU2C has developed the procurement language to solicit proposals for SU2C Dream Teams, Research Teams and other grants mechanisms in the SU2C research portfolio to increase diverse participation in... Read more
January 28, 2020
Atlanta, GA – January 28, 2020 – A team of leaders in patient advocacy and education at the Black Women’s Health Imperative (BWHI), Friends of Cancer Research (Friends), and Stand Up To Cancer (SU2C... Read more
January 28, 2020
The House Energy & Commerce health panel will review legislative proposals that aim to end gaming of the Orphan Drug Act, improve generic drug labeling and foster continuous manufacturing at a... Read more
January 21, 2020
After officially launching the "Identification and Validation of ctDNA Quality Control Materials" Initiative last fall, a team at the Foundation of the National Institutes of Health (FNIH) has... Read more
January 17, 2020
Al B. Benson III was appointed deputy chair for policy and implementation by the ECOG-ACRIN Cancer Research Group. Benson will lead EA’s efforts to strengthen collaboration between academic and... Read more
January 17, 2020
When the first personalized cancer therapies came to market more than 20 years ago, some experts predicted that the field's growing understanding of the molecular features driving tumors would alter... Read more
January 15, 2020
Executive Summary US FDA oncology chief celebrates his 20th year at the agency with a frank and wide-ranging podcast interview in which he addresses the next (two) phases of the Oncology Center of... Read more
January 14, 2020
An ongoing push to speed new medicines to patients has led to the growth of new Food and Drug Administration programs with relaxed evidence standards for approving drugs, according to an analysis... Read more